Canada Sclerotherapy Market Size & Outlook, 2020-2027
Canada sclerotherapy market, 2016-2027 (US$M)
Related Markets
Canada sclerotherapy market highlights
- The Canada sclerotherapy market generated a revenue of USD 63.4 million in 2020 and is expected to reach USD 82.9 million by 2027.
- The Canada market is expected to grow at a CAGR of 3.9% from 2021 to 2027.
- In terms of segment, detergents was the largest revenue generating agent in 2020.
- Detergents is the most lucrative agent segment registering the fastest growth during the forecast period.
Sclerotherapy market data book summary
| Market revenue in 2020 | USD 63.4 million |
| Market revenue in 2027 | USD 82.9 million |
| Growth rate | 3.9% (CAGR from 2020 to 2027) |
| Largest segment | Detergents |
| Fastest growing segment | Detergents |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Detergents, Chemical Irritants, Osmotic Agents |
| Key market players worldwide | B2Gold Corp, LGM Pharma, Troikaa Pharmaceuticals, Mylan, Perrigo Co PLC, Merz Pharma, Medi-Globe |
Other key industry trends
- In terms of revenue, Canada accounted for 7.0% of the global sclerotherapy market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In North America, U.S. sclerotherapy market is projected to lead the regional market in terms of revenue in 2027.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 494.9 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sclerotherapy Market Scope
Sclerotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada sclerotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sclerotherapy market will help companies and investors design strategic landscapes.
Detergents was the largest segment with a revenue share of 42.27% in 2020. Horizon Databook has segmented the Canada sclerotherapy market based on detergents, chemical irritants, osmotic agents covering the revenue growth of each sub-segment from 2016 to 2027.
According to the Canadian Institute of Health Information, the total healthcare expenditure in Canada was about $264 billion which is $ 7,068 per person, representing 11.6% of their total GDP. High healthcare expenditure and presence of advanced healthcare infrastructure are some key factors fueling the sclerotherapy Market in Canada.
An increasing number of obese population and rising geriatric population are encouraging individuals to opt for sclerotherapy treatment. According to the Government of Canada, 21% of the Canadian population are obese and around 17.6% of the population is above 60 years of age. These are the most likely factor for the prevalence of conditions like varicose veins.
Varicose veins is estimated to be widespread in around 20% of the Canadian population The Canadian provincial health insurance plans pays for surgical procedures like saphenous vein ligation and stripping procedures for patients with venous ulcers but endovenous techniques such as laser, radiofrequency ablation or chemical ablation are not covered by Canadian public insurance plans.
Reasons to subscribe to Canada sclerotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada sclerotherapy market databook
-
Our clientele includes a mix of sclerotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada sclerotherapy market, including forecasts for subscribers. This country databook contains high-level insights into Canada sclerotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Canada sclerotherapy market size, by agent, 2016-2027 (US$M)
Canada Sclerotherapy Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
